BGB324 (bemcentinib)

bemcentinib · BerGenBio ASA

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BGB324 (bemcentinib), covering 2025-01-14 to 2025-01-14. Get the full timeline:

Most recent: Clinical Trial Update: BGB324 in Combination With Pembrolizumab or Dabrafenib/Trametinib in Metastatic Melanoma [Phase 1, Phase 2]